Dining Out Linked to Phthalates Exposure in U.S. Population

Share this content:
Dining Out Linked to Phthalates Exposure in U.S. Population
Dining Out Linked to Phthalates Exposure in U.S. Population

THURSDAY, March 29, 2018 (HealthDay News) -- Among the U.S. population, dining out is associated with exposure to phthalates, according to a study published online March 28 in Environment International.

Using data from the National Health and Nutrition Examination Survey, Julia R. Varshavsky, Ph.D., M.P.H., from the University of California in Berkeley, and colleagues estimated cumulative phthalates exposure by calculating daily intake from metabolite concentrations in urinary spot samples for 10,253 participants. A biologically relevant metric of phthalates daily intake (Σandrogen-disruptor, µg/kg/day) was constructed by converting phthalates into anti-androgen equivalent terms prior to their summation.

Across the study population, the researchers identified a consistent positive association between dining out and Σandrogen-disruptor levels. Compared with adolescents who only consumed food at home, adolescent high consumers of foods outside the home had 55 percent higher Σandrogen-disruptor levels. There was variation by age group in the contribution of specific dining out sources to Σandrogen-disruptor levels; in children and adults, cafeteria food correlated with 15 and 64 percent higher Σandrogen-disruptor levels, respectively. Certain foods, such as sandwiches, correlated with increased Σandrogen-disruptor levels only if they were purchased away from home.

"Dining out may be an important source of biologically relevant cumulative phthalates exposure among the U.S. population," the authors write. "Future studies should evaluate modifiable production practices that remove phthalates from the food supply in addition to the efficacy of interventions that promote eating fresh foods prepared at home."

Abstract/Full Text (subscription or payment may be required)

Share this content:

is free, fast, and customized just for you!




Already a member?

Sign In Now »

Trending Activities

All Professions

Drug Lookup

Browse drugs by: BrandGenericDisease

More in Home

FDA Permits Marketing of Brain Stimulation Device for OCD

FDA Permits Marketing of Brain Stimulation Device for ...

FDA previously approved transcranial magnetic stimulation for major depression, certain migraines

Comments Open on End of NIH Review for Gene Therapy Studies

Comments Open on End of NIH Review for ...

NIH oversight panel no longer plans to review all applications for gene therapy experiments

U.S. Measles Outbreak Hits 107 Cases in 21 States, D.C.

U.S. Measles Outbreak Hits 107 Cases in 21 ...

Outbreak on track to exceed last year's; most of the people who got measles weren't vaccinated

is free, fast, and customized just for you!




Already a member?

Sign In Now »